Trial Management STREAM

41. Disclosure As A Service ROI 6/3/2020

    How do sponsors determine the ROI of Disclosure as a Service? TrialScope talks with two sponsors – a large pharmaceutical company and a smaller biotech – for their take on this. Watch the short video.

42. Are Resource Constraints Impacting Your TMF Health? 8/22/2023

    Looking to quickly expand internal TMF resources with our anytime, anywhere TMF expertise? Unlock the potential to seamlessly access specialized TMF knowledge and support by viewing this presentation.

43. Clinical Trials And TMF 101 Learning Series: 1st Session 9/20/2022

    Spark a deeper and broader understanding of the world of Drug Development, Clinical Trials, Regulations, the Trial Master File, and much more – for the industry novice as well as the guru.

44. CAR-T Cell Therapies: Advancements In Cancer Trials & Treatment 6/19/2023

    Watch as Managing Editor of Pharmaceutical Technology Jeanne Linke Northrop talks with Tanmay Jain, Sr. Director of Trial Design Solutions within Medidata AI, about the use of CAR-T cell therapies within the oncology space.

45. How RWD Reshapes Patient Recruitment Strategies 8/13/2025

    Discover how real-world data (RWD) is transforming patient recruitment by shifting from traditional site-centered methods to a patient-first approach.

46. Why Disclosure As A Service? 6/3/2020

    Two clinical trial sponsors – one larger pharmaceutical company and one smaller biotech – share with TrialScope what their main reasons were for initially considering Disclosure as a Service. Watch the short video.

47. Audit Trails: Demonstrating TMF Oversight, Completeness, & Accuracy 5/4/2023

    Listen in as experts share their knowledge and experience to provide insights on leveraging audit trails for oversight, completeness, and accuracy of TMF management systems.

48. Sponsors' Advice On Disclosure As A Service 6/3/2020

    Representatives from Teva and Lung Biotechnology share their insights for other sponsors considering Disclosure as a Service. Watch the short video now.

49. Cognitive, Pharmacodynamic Testing During FIH CNS Trials 5/22/2024

    A comprehensive review of optimal timing and methodologies for cognitive and pharmacodynamic testing during first-in-human trials on CNS-active compounds.

50. Why Disclosure Assessments Are The First Step To Improvement 1/8/2019

    Whether your organization lacks formal disclosure policies and procedures, or has longstanding SOPs in place, the best way to gauge the effectiveness of your clinical trial disclosure process is via a third-party assessment.